browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
75996d10-9073-4ce8-886a-8767440f845b
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 21:05:10
Income (reported)
—
Expenses (reported)
$400,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

PHLOW CORPORATION

Generic Pharmaceutical Manufacturing

Contact
VALERIE JEWETT
Phone
+1 804-921-2725
Address
zip:23219, city:Richmond, state:VA, street:1001 Haxall Point, #1B
Client

PHLOW CORPORATION

State
VA
Country
US
Government-entity client
false
Effective date
2021-06-08
Issues lobbied + lobbyists (3)

BUD — Budget/Appropriations

FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (no bill numbers); FY27 Department of Defense Appropriations (no bill numbers)

Lobbyists:

Government entities lobbied: Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Office of Management & Budget (OMB); SENATE

HCR — Health Issues

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).

Lobbyists:

Government entities lobbied: Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Office of Management & Budget (OMB); SENATE

MAN — Manufacturing

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).

Lobbyists:

Government entities lobbied: Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Office of Management & Budget (OMB); SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.